Show simple item record

dc.contributor.advisorHernández Leiva, Edgar 
dc.creatorHernández Valderrama, Marcela Andrea 
dc.creatorFlórez Cárdenas, Mónica Marcela 
dc.date.accessioned2016-07-05T15:08:47Z
dc.date.available2016-07-05T15:08:47Z
dc.date.created2016-05-18
dc.date.issued2016 
dc.identifier.urihttp://repository.urosario.edu.co/handle/10336/12113
dc.descriptionIntroducción: Entre las diferentes herramientas clínicas para evaluar la presencia de enfermedad coronaria mediante puntajes, la más usada es la Escala de Riesgo cardiovascular de Framingham. Desde hace unos años, se creó el puntaje de calcio coronario el cual mide el riesgo cardiovascular según la presencia de placas ateromatosas vistas por tomografía computarizada. Se evaluó la asociación entre la escala de Framigham y el puntaje de calcio coronario en una población de sujetos sanos asintomáticos. Metodología: Se realizó un estudio transversal para evaluar la asociación entre el puntaje de calcio coronario y la escala de Framingham en sujetos asintomáticos que se practicaron exámen médico preventivo en la Fundación Cardioinfantil- Instituto de Cardiología (FCI-IC) en el periodo comprendido entre 1 de Julio 2011 hasta el 31 de octubre de 2015. Resultados: Se evaluaron 262 pacientes en total. La prevalencia de riesgo cardiovascular fue bajo en un 77.86% de la población, medio en 18.70% y alto en 3.44%, según la escala de Framingham. El riesgo cardiovascular según el puntaje de Calcio coronario fue nulo 70.99%, bajo en 21.75%, medio en 4.19%, severo en 3.05%. Se encontró una asociación entre ambos puntajes para riesgo estadísticamente significativa (p0,00001) Discusión: El riesgo cardiovascular establecido por escala de Framingham se relaciona de forma significativa con la presencia de placas aterioscleróticas. El estudio demostró que en una muestra de sujetos asintomáticos, hay una alteración estructural coronaria temprana.
dc.description.abstractBackround: Among the different clinical tools to assess the presence of coronary disease by scores, the most used is the scale of Framingham cardiovascular risk. In recent years, the coronary calcium score was created, and it measures cardiovascular risk due to the presence of atheromatous plaques seen by CT. It was intended to assess the association between the scale of Framingham and coronary calcium score in a population of healthy asymptomatic subjects Methodology A cross-sectional study was conducted to evaluate the association between coronary calcium score and Framingham scale in asymptomatic subjects who practiced preventive medical examination at Cardioinfantil-Institute of Cardiology (FCI-IC) Foundation in the period from July 1, 2011 until October 31, 2015. Results 262 patients were evaluated. The prevalence of cardiovascular risk was low in 77.86% of the population, moderate in 18.70% and high in 3.44% , according to the Framingham scale. The cardiovascular risk according to the coronary calcium score was zero in 70.99% in 21.75% low, in medium 4.19%, and in 3.05% severe. An association was found between both scores to assess for risk, with statistically significant results (p0,00001) Discussion Established cardiovascular risk by Framingham score is significantly associated with the presence of atherosclerotic plates. The study showed that in a sample of asymptomatic subjects, there is an early coronary structural alteration.
dc.format.mimetypeapplication/pdf
dc.language.isospa
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/2.5/co/
dc.sourceinstname:Universidad del Rosario
dc.sourcereponame:Repositorio Institucional EdocUR
dc.subjectRiesgo cardiovascular
dc.subjectPuntaje de calcio coronario
dc.subject.ddcEnfermedades 
dc.subject.lembCardiología
dc.titleAsociación entre la escala de riesgo Framingham y el puntaje de calcio coronario
dc.typebachelorThesis
dc.publisherUniversidad del Rosario
dc.creator.degreeEspecialista en Radiología
dc.publisher.programEspecialización en Radiología
dc.publisher.departmentFacultad de Medicina
dc.subject.keywordcardiovascular risk
dc.subject.keywordcoronary calcium score
dc.rights.accesRightsinfo:eu-repo/semantics/openAccess
dc.subject.decsCardiología
dc.subject.decsCardiopatías
dc.subject.decsTomografía
dc.type.spaTrabajo de grado
dc.rights.accesoAbierto (Texto completo)
dc.type.hasVersioninfo:eu-repo/semantics/acceptedVersion
dc.source.bibliographicCitationSandfort V, Lima JA, Bluemke DA. Noninvasive Imaging of Atherosclerotic Plaque Progression: Status of Coronary Computed Tomography Angiography. Circ Cardiovasc Imaging. 2015;8(7):e003316.
dc.source.bibliographicCitation2. Roth GA, Forouzanfar MH, Moran AE, Barber R, Nguyen G, Feigin VL, et al. Demographic and epidemiologic drivers of global cardiovascular mortality. N Engl J Med. 2015;372(14):1333-41.
dc.source.bibliographicCitation3. Hobbs FD, Jukema JW, Da Silva PM, McCormack T, Catapano AL. Barriers to cardiovascular disease risk scoring and primary prevention in Europe. QJM. 2010;103(10):727-39.
dc.source.bibliographicCitation4. Kannel WB, McGee D, Gordon T. A general cardiovascular risk profile: the Framingham Study. Am J Cardiol. 1976;38(1):46-51.
dc.source.bibliographicCitation5. SOCIAL MDSYP. Análisis de Situación en Salud 2014. 2014.
dc.source.bibliographicCitation6. Mortality GBD, Causes of Death C. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;385(9963):117-71.
dc.source.bibliographicCitation7. Bloom DE, Cafiero, . ., an -Llopis, E., Abrahams-Gessel, S., Bloom, L.R., Fathima, S., Feigl, A.B., Gaziano, T., Mowafi, M., Pandya, A., Prettner, K., Rosenberg, L., Seligman, B., Stein, A.Z., & Weinstein, C. . The Global Economic Burden of Noncommunicable Diseases. Geneva: World Economic Forum.2011.
dc.source.bibliographicCitation8. Eichler K, Zoller M, Tschudi P, Steurer J. Barriers to apply cardiovascular prediction rules in primary care: a postal survey. BMC Fam Pract. 2007;8:1.
dc.source.bibliographicCitation9. Arbab-Zadeh A, Nakano M, Virmani R, Fuster V. Acute coronary events. Circulation. 2012;125(9):1147-56.
dc.source.bibliographicCitation10. Zimarino M, Prati F, Marano R, Angeramo F, Pescetelli I, Gatto L, et al. The value of imaging in subclinical coronary artery disease. Vascul Pharmacol. 2016.
dc.source.bibliographicCitation11. Kim HY, Choi JH. How to Utilize Coronary Computed Tomography Angiography in the Treatment of Coronary Artery Disease. J Cardiovasc Ultrasound. 2015;23(4):204-8.
dc.source.bibliographicCitation12. Gaziano TA, Bitton A, Anand S, Abrahams-Gessel S, Murphy A. Growing epidemic of coronary heart disease in low- and middle-income countries. Curr Probl Cardiol. 2010;35(2):72-115.
dc.source.bibliographicCitation13. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, et al. Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation. 2016;133(4):e38-e360.
dc.source.bibliographicCitation14. Aikawa M, Libby P. The vulnerable atherosclerotic plaque: pathogenesis and therapeutic approach. Cardiovasc Pathol. 2004;13(3):125-38.
dc.source.bibliographicCitation15. Stary HC, Chandler AB, Dinsmore RE, Fuster V, Glagov S, Insull W, Jr., et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Arterioscler Thromb Vasc Biol. 1995;15(9):1512-31.
dc.source.bibliographicCitation16. Kaul P, Douglas PS. Atherosclerosis imaging: prognostically useful or merely more of what we know? Circ Cardiovasc Imaging. 2009;2(2):150-60.
dc.source.bibliographicCitation17. Greenland P, Alpert JS, Beller GA, Benjamin EJ, Budoff MJ, Fayad ZA, et al. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2010;56(25):e50-103.
dc.source.bibliographicCitation18. Kalia NK, Miller LG, Nasir K, Blumenthal RS, Agrawal N, Budoff MJ. Visualizing coronary calcium is associated with improvements in adherence to statin therapy. Atherosclerosis. 2006;185(2):394-9.
dc.source.bibliographicCitation19. Orakzai RH, Nasir K, Orakzai SH, Kalia N, Gopal A, Musunuru K, et al. Effect of patient visualization of coronary calcium by electron beam computed tomography on changes in beneficial lifestyle behaviors. Am J Cardiol. 2008;101(7):999-1002.
dc.source.bibliographicCitation20. Andrus B, Lacaille D. 2013 ACC/AHA guideline on the assessment of cardiovascular risk. J Am Coll Cardiol. 2014;63(25 Pt A):2886.
dc.source.bibliographicCitation21. Brotons C, Moral I, Soriano N, Cuixart L, Osorio D, Bottaro D, et al. Impacto de la utilización de las diferentes tablas SCORE en el cálculo del riesgo cardiovascular. Revista Española de Cardiología. 2014;67(02):94-100.
dc.source.bibliographicCitation22. Expert Panel on D, Evaluation, and Treatment of High Blood Cholesterol in A. EXecutive summary of the third report of the national cholesterol education program (ncep) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel iii). JAMA. 2001;285(19):2486-97.
dc.source.bibliographicCitation23. Mahmood SS, Levy D, Vasan RS, Wang TJ. The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective. Lancet. 2014;383(9921):999-1008.
dc.source.bibliographicCitation24. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97(18):1837-47.
dc.source.bibliographicCitation25. Hecht HS. Coronary artery calcium scanning: past, present, and future. JACC Cardiovasc Imaging. 2015;8(5):579-96.
dc.source.bibliographicCitation26. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M, Jr., Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol. 1990;15(4):827-32.
dc.source.bibliographicCitation27. Messenger B, Li D, Nasir K, Carr JJ, Blankstein R, Budoff MJ. Coronary calcium scans and radiation exposure in the multi-ethnic study of atherosclerosis. Int J Cardiovasc Imaging. 2016;32(3):525-9.
dc.source.bibliographicCitation28. Willemink MJ, Vliegenthart R, Takx RA, Leiner T, Budde RP, Bleys RL, et al. Coronary artery calcification scoring with state-of-the-art CT scanners from different vendors has substantial effect on risk classification. Radiology. 2014;273(3):695-702.
dc.source.bibliographicCitation29. Rumberger JA, Simons DB, Fitzpatrick LA, Sheedy PF, Schwartz RS. Coronary artery calcium area by electron-beam computed tomography and coronary atherosclerotic plaque area. A histopathologic correlative study. Circulation. 1995;92(8):2157-62.
dc.source.bibliographicCitation30. Kral BG, Becker LC, Vaidya D, Yanek LR, Qayyum R, Zimmerman SL, et al. Noncalcified coronary plaque volumes in healthy people with a family history of early onset coronary artery disease. Circ Cardiovasc Imaging. 2014;7(3):446-53.
dc.source.bibliographicCitation31. Joshi PH, Patel B, Blaha MJ, Berry JD, Blankstein R, Budoff MJ, et al. Coronary artery Calcium predicts Cardiovascular events in participants with a low lifetime risk of Cardiovascular disease: The Multi-Ethnic Study of Atherosclerosis (MESA). Atherosclerosis. 2016;246:367-73.
dc.source.bibliographicCitation32. Okwuosa TM, Greenland P, Ning H, Liu K, Bild DE, Burke GL, et al. Distribution of coronary artery calcium scores by Framingham 10-year risk strata in the MESA (Multi- Ethnic Study of Atherosclerosis) potential implications for coronary risk assessment. J Am Coll Cardiol. 2011;57(18):1838-45.
dc.source.bibliographicCitation33. Rumberger JA BB, Rader DJ, Kondos G. Electron beam computed tomographic coronary calcium scanning: a review and guidelines for use in asymtomatic persons. Mayo Clin Proc. 1999;74(3):243-52.
dc.source.bibliographicCitation34. James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311(5):507-20.
dc.source.bibliographicCitation35. Expert Panel on Detection E, Treatment of High Blood Cholesterol in A. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001;285(19):2486-97.
dc.source.bibliographicCitation36. McClelland RL, Jorgensen NW, Budoff M, Blaha MJ, Post WS, Kronmal RA, et al. 10-Year Coronary Heart Disease Risk Prediction Using Coronary Artery Calcium and Traditional Risk Factors: Derivation in the MESA (Multi-Ethnic Study of Atherosclerosis) With Validation in the HNR (Heinz Nixdorf Recall) Study and the DHS (Dallas Heart Study). J Am Coll Cardiol. 2015;66(15):1643-53.
dc.source.bibliographicCitation37. Choi EK, Choi SI, Rivera JJ, Nasir K, Chang SA, Chun EJ, et al. Coronary computed tomography angiography as a screening tool for the detection of occult coronary artery disease in asymptomatic individuals. J Am Coll Cardiol. 2008;52(5):357-65.
dc.source.bibliographicCitation38. Polonsky TS, McClelland RL, Jorgensen NW, Bild DE, Burke GL, Guerci AD, et al. Coronary artery calcium score and risk classification for coronary heart disease prediction. JAMA. 2010;303(16):1610-6.
dc.source.bibliographicCitation39. Elias-Smale SE, Proenca RV, Koller MT, Kavousi M, van Rooij FJ, Hunink MG, et al. Coronary calcium score improves classification of coronary heart disease risk in the elderly: the Rotterdam study. J Am Coll Cardiol. 2010;56(17):1407-14.
dc.source.bibliographicCitation40. Min JK, Lin FY, Gidseg DS, Weinsaft JW, Berman DS, Shaw LJ, et al. Determinants of coronary calcium conversion among patients with a normal coronary 54 Marcela Andrea Hernandez Mónica Marcela Flórez calcium scan: what is the "warranty period" for remaining normal? J Am Coll Cardiol. 2010;55(11):1110-7.
dc.source.bibliographicCitation41. Budoff MJ, Young R, Lopez VA, Kronmal RA, Nasir K, Blumenthal RS, et al. Progression of coronary calcium and incident coronary heart disease events: MESA (Multi- Ethnic Study of Atherosclerosis). J Am Coll Cardiol. 2013;61(12):1231-9.
dc.source.bibliographicCitation42. Paixao AR, Ayers CR, El Sabbagh A, Sanghavi M, Berry JD, Rohatgi A, et al. Coronary Artery Calcium Improves Risk Classification in Younger Populations. JACC Cardiovasc Imaging. 2015;8(11):1285-93.
dc.source.bibliographicCitation43. REPUBLICA DE COLOMBIA MDS. RESOLUCION No 008430 DE 1993 1993 [Available from: http://www.unisabana.edu.co/fileadmin/Documentos/Investigacion/comite_de_etica/Res__ 8430_1993_-_Salud.pdf.
dc.rights.ccAtribución-NoComercial-SinDerivadas 2.5 Colombia
dc.rights.licenciaEL AUTOR, manifiesta que la obra objeto de la presente autorización es original y la realizó sin violar o usurpar derechos de autor de terceros, por lo tanto la obra es de exclusiva autoría y tiene la titularidad sobre la misma. PARGRAFO: En caso de presentarse cualquier reclamación o acción por parte de un tercero en cuanto a los derechos de autor sobre la obra en cuestión, EL AUTOR, asumirá toda la responsabilidad, y saldrá en defensa de los derechos aquí autorizados; para todos los efectos la universidad actúa como un tercero de buena fe. EL AUTOR, autoriza a LA UNIVERSIDAD DEL ROSARIO, para que en los términos establecidos en la Ley 23 de 1982, Ley 44 de 1993, Decisión andina 351 de 1993, Decreto 460 de 1995 y demás normas generales sobre la materia, utilice y use la obra objeto de la presente autorización. -------------------------------------- POLITICA DE TRATAMIENTO DE DATOS PERSONALES. Declaro que autorizo previa y de forma informada el tratamiento de mis datos personales por parte de LA UNIVERSIDAD DEL ROSARIO para fines académicos y en aplicación de convenios con terceros o servicios conexos con actividades propias de la academia, con estricto cumplimiento de los principios de ley. Para el correcto ejercicio de mi derecho de habeas data cuento con la cuenta de correo habeasdata@urosario.edu.co, donde previa identificación podré solicitar la consulta, corrección y supresión de mis datos.


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

http://creativecommons.org/licenses/by-nc-nd/2.5/co/
Except where otherwise noted, this item's license is described as http://creativecommons.org/licenses/by-nc-nd/2.5/co/

 

Reconocimientos: